Evaluation of the effectiveness of women's empowerment in predicting infected COVID-19 outcomes.
Not Applicable
- Conditions
- COVID-19.Coronavirus as the cause of diseases classified elsewhereB97.2
- Registration Number
- IRCT20221228056969N1
- Lead Sponsor
- WHO Eastern Mediterranean Regional Office
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 303
Inclusion Criteria
Housewives with an age range of 30-60years
No renal disease or diabetes, mental and learning problems, vision, and hearing problems
Has literacy
Internet access
Having a computer or smartphone
Exclusion Criteria
Pregnant women / intention to conceive or breastfeed
Subjects with COVID-19 disease
Subjects who are recovering of COVID-19
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunoglobulin G (IgG) and Immunoglobulin M (Ig M) antibodies titers. Timepoint: This study was conducted at three time points: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: enzyme-linked immunosorbent assay, using kits (ELISA; Pishtaz, Iran).
- Secondary Outcome Measures
Name Time Method